You are here

PwC to employers: Focus on all medical prices—and not just drug prices

Health plans expected to continue pushing for value-based payment arrangements.

Experts at PricewaterhouseCoopers’s Health Research Institute project that medical costs in the employer insurance market will increase by 6% next year. The good news: that falls within the range of 5.5%–7% that costs have been going up the last several years. Still the year-in, year-out cost increases in health care are not sustainable, says PwC. Efforts to rein in utilization have run their course, according to PwC’s health care experts, so employers need to tackle prices if they want to control their medical costs—and not just drug prices that have been the focus recently.

Source: PricewaterhouseCoopers

More Headlines

Agency says products for sexual enhancement, weight loss, and bodybuilding have hidden drugs and chemicals.
A meta-analysis that included 18 million participants found no protection from heart disease or stroke.
There is a small difference between them and biosimilars that physicians, patients, and insurers should be aware of.
It will nearly quadruple within the next five years, according to a new report, though concerns about how they’re manufactured remain.
Some of that can be chalked up to the differences in cost of living from place to place, but not all.
One of the proposed changes makes remote patient monitoring an allowable cost.
European researchers looked at arthritis’ patients reactions when being switched from etanercept or nfliximab.
Puts down $700 million to buy nearly 50% of Samsung.
The move comes even though some of the pharma company’s rivals have promised to raise prices only once a year.